| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,852,133 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$5,852,133 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-03 |
4 |
OE |
$16.64 |
$166,400 |
D/D |
10,000 |
28,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-03 |
4 |
AS |
$82.00 |
$820,000 |
D/D |
(10,000) |
18,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-06 |
4 |
S |
$84.31 |
$843,080 |
D/D |
(10,000) |
18,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-06 |
4 |
OE |
$20.56 |
$216,659 |
D/D |
10,000 |
25,303 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-03-02 |
4 |
OE |
$20.56 |
$51,400 |
D/D |
2,500 |
20,714 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-03-26 |
4 |
AS |
$46.74 |
$934,800 |
D/D |
(20,000) |
41,428 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-03-26 |
4 |
OE |
$8.49 |
$169,700 |
D/D |
20,000 |
61,428 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-05-08 |
4 |
OE |
$10.28 |
$51,400 |
D/D |
5,000 |
46,428 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-12-23 |
4 |
AS |
$26.01 |
$687,419 |
D/D |
(26,428) |
20,000 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2010-01-07 |
4 |
OE |
$7.27 |
$108,352 |
D/D |
14,904 |
34,904 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2010-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
703 |
34,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-04-29 |
4 |
AS |
$22.00 |
$103,416 |
D/D |
(4,700) |
29,501 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-05-04 |
4 |
AS |
$22.75 |
$120,575 |
D/D |
(5,300) |
24,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-05-18 |
4 |
OE |
$6.00 |
$307,235 |
D/D |
44,314 |
34,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-05-18 |
4 |
AS |
$25.00 |
$1,108,027 |
D/D |
(44,314) |
24,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-06-06 |
4 |
OE |
$8.63 |
$43,150 |
D/D |
5,000 |
29,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
466 |
28,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
AS |
$24.05 |
$524,338 |
D/D |
(21,804) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
OE |
$8.63 |
$188,169 |
D/D |
21,804 |
44,539 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
D |
$24.15 |
$144,924 |
D/D |
(6,000) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-15 |
4 |
OE |
$9.04 |
$239,885 |
D/D |
26,536 |
49,271 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-15 |
4 |
AS |
$25.00 |
$663,503 |
D/D |
(26,536) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-16 |
4 |
OE |
$9.04 |
$31,315 |
D/D |
3,464 |
26,199 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-16 |
4 |
AS |
$25.00 |
$86,600 |
D/D |
(3,464) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-09-17 |
4 |
AS |
$28.00 |
$140,000 |
D/D |
(5,000) |
17,735 |
0 |
- |
|
140 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
